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Cassette systems for creating intergeneric hybrid
ATCases were constructed.  An MluI restriction enzyme site
was introduced at the carbamoylphosphate binding site
within the pyrB genes of both Pseudomonas putida and
Escherichia coli.  Two hybrids, E. coli pyrB polar domain
fused with P. putida pyrB equatorial domain and P. putida
pyrB polar domain fused with E. coli pyrB equatorial
domain, are possible.  The intergeneric E. coli-P. putida
hybrid pyrB gene was constructed and found to encode an
active ATCase which complemented an E. coli Pyr- strain.
These hybrids are useful for kinetic and expression studies
of ATCase in E. coli.
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INTRODUCTION
The study of pyrimidine biosynthesis is important due
to the role that pyrimidines play in forming the genetic
material that is necessary for cellular growth and for the
passing of genetic information to subsequent generations.
Pyrimidines serve as building blocks in the informational
macromolecules ribonucleic acid (RNA) and deoxyribonucleic
acid (DNA).  They are also found in all cell membranes as
UDP-glucose or dTDP-rhamnose for example.  Pyrimidines are
found in all organisms and are six-membered, aromatic
heterocyclic ring compounds.  Pyrimidine nucleosides
consist of nitrogenous bases, cytosine and thymine in DNA
and cytosine and uracil in RNA, linked to a pentose sugar.
In DNA the sugar is 2’-deoxyribose, whereas in RNA it is
ribose.  Nucleotides are nucleosides with phosphate groups
added.
Uridine-5’-monophosphate (UMP; Fig. 1) serves as a
precursor for all the pyrimidine nucleotides.  The
biosynthesis of UMP, referred to as the pyrimidine
biosynthetic pathway, is accomplished in six enzymatic
steps.  This pathway appears to be universal and follows
2
the same sequence in all organisms thus far studied
including bacteria, fungi, plants, and animals (O’Donovan &
Neuhard, 1970; Neuhard & Kelln, 1996).
Pyrimidine biosynthetic pathway.
The enzyme carbamoylphosphate synthetase (CPSase, EC
6.3.5.5) catalyzes the first step in pyrimidine synthesis.
The reaction utilizes bicarbonate, ammonium ions or
glutamine, and consumes two molecules of adenosine-5’-
triphosphate (ATP) leading to the formation of one molecule
of carbamoylphosphate and adenosine-5’-diphosphate (ADP)
(Anderson & Meister, 1965; Kalman et al., 1966).
Carbamoylphosphate is required for both arginine and
pyrimidine synthesis (Abdelal et al., 1969).
The first committed step in pyrimidine biosynthesis is
the production of carbamoylaspartate (CAA) by aspartate
transcarbamoylase (ATCase, EC 2.1.3.2).  Aspartate is
carbamoylated at the amino group, producing CAA and
releasing inorganic phosphate.  The enzyme dihydroorotase
(DHOase, EC 3.5.2.3) then catalyzes the cyclization of CAA,
resulting in the release of a molecule of water and
production of dihydroorotate (DHO).
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Following this, DHO is oxidized to orotate (OA) in a
reaction catalyzed by dihydroorotate dehydrogenase
(DHOdehase, EC 1.3.3.1).  The first pyrimidine nucleotide
is then produced by the transfer of ribose-5’-phosphate
from 5’-phosphoribosyl-1’-pyrophosphate (PRPP) to OA to
form orotidine-5’-monophosphate (OMP), a reaction catalyzed
by orotate phosphoribosyltransferase (OPRTase, EC
2.2.4.10).  OMP is decarboxylated by the enzyme OMP
decarboxylase (OMPdecase, EC 4.1.1.23) in the final step in
the production of UMP.
UMP serves as a precursor for the production of the
pyrimidine nucleoside triphosphates, uridine-5’-
triphosphate (UTP) and cytidine-5’-triphosphate (CTP).  In
sequential steps, UMP is further phosphorylated to uridine-
5’-diphosphate (UDP) by the highly specific UMP kinase (EC
2.7.4.4).  A non-specific enzyme, nucleoside diphosphate
kinase (NDK, EC 2.7.4.6), further phosphorylates UDP to
form UTP.  CTP synthetase (EC 6.3.4.2) is responsible for




Aspartate transcarbamoylase (ATCase) catalyzes the
first committed step in pyrimidine biosynthesis (Fig. 1).
Aspartate transcarbamoylase of Escherichia coli is the
epitome of a regulatory enzyme, exhibiting all the
hallmarks of allosteric kinetic behavior.  Thus, ATCase has
emerged as one of the best characterized bacterial enzymes
to date.  Three classes of bacterial ATCase (A-C) have been
described, based on varying molecular weights of the
holoenzyme, quaternary structure (Fig. 2), and enzyme
kinetics (Bethell & Jones, 1969; Wild et al., 1980).
Representative of Class C ATCase: Bacillus subtilis.
  A representative of the class C ATCase is found in
Bacillus subtilis (Brabson and Switzer, 1975).  Class C
ATCases are 100 kDa catalytic trimers that are not
associated with any other polypeptides.  This form of
ATCase is not regulated by nucleotide effectors in Bacillus
or Staphylococcus and thus displays Michaelis-Menten
saturation kinetics when velocity-substrate plots are made.
However, the ATCase of wheat (Yon, 1984), also found as a
catalytic trimer, exhibits a sigmoid curve when velocity-
5
substrate plots are made, indicating that it is also
regulated.
Representative of Class B ATCase: Escherichia coli.
The E. coli ATCase is a representative of the class B
ATCases.  Class B ATCase holoenzymes have a molecular mass
of ~310 kDa, are composed of two catalytic homotrimers
coupled to three regulatory homodimers, are allosterically
regulated and bind substrates cooperatively which results
in sigmoidal saturation kinetics when velocity-substrate
plots are made.  The ATCase of E. coli is activated by ATP
and inhibited by CTP and UTP in the presence of CTP
(O’Donovan et al., 1989).  The genes pyrBI of E. coli
(Pauza et al., 1982; Roof et al., 1982) encode the
dodecameric enzyme form of aspartate transcarbamoylase
(Fig. 3).  Six identical catalytic polypeptides, organized
as two enzymatically functional catalytic trimers (c3) and
six identical regulatory polypeptides organized as three
regulatory dimers (r2) define the holoenzyme.  The 2c3:3r2
dodecameric structure is conserved among the enteric
ATCases.  E. coli pyrB encodes the catalytic polypeptide of
34 kDa, while pyrI encodes the regulatory polypeptide of 17
kDa.  In E. coli the nucleotide effectors bind to the
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dimeric regulatory subunits encoded by the pyrI gene (red
arrow in Fig. 3).
Representative of Class A ATCase: Pseudomonas putida.
The P. putida ATCase is a representative of the class
A ATCase (Schurr et al., 1995).  Class A ATCase holoenzymes
have molecular masses of about 480 kDa, contain a
dodecameric structure, and exhibit hyperbolic curves when
velocity-substrate plots are made.  Pyrophosphate, ATP,
UTP, and CTP inhibited the ATCase of P. putida, examined by
Condon et al. (Condon et al., 1976).  The genes pyrBC’ of
P. putida (Schurr et al., 1995) encode the dodecameric
holoenzyme form of aspartate transcarbamoylase (Fig. 3).
The pyrB gene encodes a 36 kDa polypeptide that does not
produce an active trimer as does E. coli and Bacillus (Fig.
4 and 5).  To be active, the pyrB gene requires the
participation of the overlapping pyrC’ gene which, encodes
a DHO-ase like 46 kDa PyrC’ polypeptide to produce a 480
kDa dodecameric holoenzyme.  The enzyme is regulated by ATP
and to a lesser extent by UTP and CTP (Schurr et al.,
1995).  The 46 kDa chain is not a homolog of the class B 17
kDa regulatory polypeptide, since the binding site for
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nucleotide effectors has been located on the 36 kDa chain
(Shepherdson & McPhail, 1993).
Background information and research.
Computer comparisons of P. putida ATCase with other
known ATCases using the Pileup program of the University of
Wisconsin GCG Package revealed an 11 amino acid extension
at the amino terminus.  This 11 amino acid overhang did not
align with any other known bacterial or eukaryotic ATCase
amino acid sequences.  A comparison of the amino acids of
the overhang with those of the regulatory polypeptide of E.
coli suggested that the N-terminal extension contained a
possible nucleotide binding site for effectors (Kumar et
al., 1994).
From this information the following hypothesis was
derived: namely that the effector binding site (regulatory
region) for the P. putida ATCase holoenzyme is located at
the N-terminus region of the pyrB encoded 36 kDa
polypeptide.  Three lines of evidence suggest that this
binding site appears at the N-terminus.  (1) Bergh & Evans,
1993, in P. fluorescens used labeled ATP to show that ATP
bound to the 36 kDa polypeptide encoded by the pyrB gene,
(2) GCG motif computer analysis showed that a putative ATP
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binding site was located at the N-terminus region of the
pyrB gene of P. putida (Schurr et al., 1995), and (3) Alan
Kumar showed by constructing various deletion mutants of
the P. putida ATCase, that ATP binding was indeed localized
at the N-terminus region of the pyrB gene (Kumar et al.,
1994).
A second hypothesis postulates that the 11 amino acid
overhang of P. putida PyrB does not allow for proper trimer
formation thereby precluding catalytic trimer activity
(Fig. 5) (Kumar et al. 1999).
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METHODS
Bacterial strains and plasmids used.
The bacterial stains and plasmids to be used are listed in
Table 1.
Table 1: Strains and Plasmids used.
Strain or plasmid Genotype or Description Source
Strains
E. coli TB2 !pyrBI, argF W. D. Roof
E. coli DH5α F-, φ80dlacZ∆M15, ∆(lacZYA-argF)
U169, deoR, recA1, endA1, hsdR17,
(rk
-mk




PALTER-Ex1 Tet, Amp, selectable markers, SP6,
T7, tac promoters, lacZ
PROMEGA
pAK10 P. putida pyrB; 1-kbp insert in pUC19
with orientation identical to that of
the lac promoter         
A. P. Kumar
pBJR28 E. coli pyrB; 1-kbp insert in pUC18 J. R. Ruley




DH5α allows for the prevention of undesirable restriction
of cloned DNA and recombination with host chromosomal DNA
because DH5α is recA- and lacks the E. coli K restriction
system.  DH5α is also lacZ- (∆ α-lac) which allows for
blue-white colony selection when complemented with the α-
polypeptide encoded by various vectors.  TB2 is a strain of
E. coli with an extensive deletion within the argI-pyrBI
region that eliminates ATCase activity.
Media and growth conditions.
E. coli strains DH5" and TB2 were grown and maintained
in Luria-Bertani (LB) broth (10 g/l Difco Bacto-Tryptone, 5
g/l Difco Yeast Extract, and 10 g/l sodium chloride) or LB
agar (15 g/l Difco Agar).  E. coli TB2 was also grown in
defined medium, E. coli minimal medium (Ecmm) broth (10.5
g/l dibasic K2HPO4, 4.5 g/l monobasic KH2PO4, 1 g/l (NH4)2SO4,
0.5 g/l Na3citrate, 1 ml 1 M MgSO4, 1 ml 1000x B1
(thiamine), 10 ml 20% dextrose or .2% carbon source ) or
Ecmm agar (15 g/l Difco Agar).  These cultures were grown
at 37°C, and liquid cultures shaken at 250 rpm in a New
Brunswick Scientific Co. Series 25 Incubator Shaker.
Antibiotics were added to the medium depending upon which
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plasmids the cells contained, as follows: cells containing
pAK10, pBJR28, pBpals, pBEaAS, pNELLS, pNPS, pCELLS, pCPS,
pBEP, and pUC19 received 100 µg of ampicillin per ml, cells
which contained pALTER-Ex1, pBpals, and pBEaAS received
12.5 mg tetracycline in 80% ethanol per ml, and cells which
contained pDBPC’ received 60 #g kanamycin per ml.
Preparation of cell extracts.
Cell extract was prepared by breaking the cells using
sonication.  Cell pellets from freshly harvested cells were
resuspended in the appropriate breaking buffer for the
assays to be performed.  Typically, 1 ml of ATCase breaking
buffer (2 mM β-mercaptoethandol, 20 µM ZnSO4, and 50 mM
Tris-HCl, pH 8.0) was added per 1 g wet weight of pellet.
The cell suspension was sonicated using a Branson Cell
Disruptor 22 for 5 min sonication per sample.  The power
setting were set at 3 for output control and pulse for a
50% duty cycle.  The tip contained a diameter of 5 mm
capable of vibrating at 20 kiloHertz.  The sonicated
suspension was transferred to a 50 ml oak ridge and
centrifuged at 4°C for 30 min at 33,000 x g in a Sorvall RC5
(SA600 rotor).  The resulting supernatant was transferred
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to a sterile 15 ml, disposable conical tube and stored at
4°C until the cell extract was analysed by ATCase activity
gel.
Preparation of competent cells for transformation.
Escherichia coli DH5α and TB2 competent cells were
produced according to a slight modification of the
procedure of Dagert & Ehrich (1979).  A single colony of E.
coli DH5α or TB2 was picked from a LB agar plate with a
sterile inoculating loop and used to inoculate 5 ml of
sterile LB broth.  The bacterial culture was grown
overnight at 37°C with shaking at 250 rpm.  A sterile flask
containing 50 ml of LB Broth was then inoculated with 500 µl
of the overnight culture and grown, typically 2-3 hours (h)
at 37°C with shaking at 250 rpm until an absorbency reading
at 650 nm reached between 0.2 and 0.5.  A loopful of the
culture was then streaked onto an LB plate, which was
incubated overnight at 37°C to check purity.  The remainder
of the cell culture was then transferred aseptically to a
50 ml disposable, conical tube and chilled on ice for 20
min.
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The cells were harvested by centrifugation in a
Sorvall RT6000B Refrigerated Centrifuge for 10 min at 4°C in
a Sorvall H1000B rotor at 1,800 x g.  The supernatant was
poured off, and the pellet was resuspended in 20 ml of cold
(0-4°C) 0.1 M CaCl2.  Then, the cells were harvested by
centrifugation at 833 x g for 15 min.  After the
supernatant was poured off, cells were resuspended by
gentle vortexing in 2 ml of 0.1 M CaCl2 and then stored
overnight on ice in a 4°C refrigerator.  Next, 150 µl of
sterile 100% glycerol was added and mixed to achieve a
final concentration of 15% glycerol.  Aliquots of 400 µl
were distributed to 0.5 ml microcentrifuge tubes and either
kept on ice for use within a few hours or stored at –80°C
for up to 1 month.
Transformation of DNA into E. coli DH5α and TB2
strains were carried out using the heat shock method of
Mercer and Loutit, 1979.
Isolation of plasmid DNA by alkaline lysis.
Plasmid DNA (pDNA) was isolated according to the
alkaline lysis method (Zhou et al., 1990).  After
incubation of transformed cells overnight at 37°C with
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shaking at 250 rpm, 1.5 ml of the 5 ml culture was
transferred to a sterile 1.5 ml microcentrifuge tube.  The
1.5 ml culture was centrifuged for 1 min. at 10,000 x g in
a Savant Speed Fuge HSC10K microcentrifuge while the
remainder of the overnight culture was stored at 4°C.  The
supernatant was poured off and the bacterial pellet
resuspended by vortexing in 300 µl TENS solution (77.5%
Tris-EDTA (TE) Buffer, pH 8, 0.1 M NaOH, and 0.5% SDS).
This tube was then placed on ice and 150 µl of 3 M sodium
acetate, pH 5.2, was added.  Then the contents of the tube
were mixed by gentle vortex and placed on ice.  In order to
pellet the cell debris and most of the chromosomal DNA, the
tube was centrifuged for 2 min at 10,000 x g at 4°C, and the
supernatant, approximately 450 µl, was transferred to a
fresh, 1.5 ml microcentrifuge tube.  Next, two volumes, 900
µl, of 100% cold ethanol (EtOH) was added and the tube was
placed on dry ice (-78.5°C solid carbon dioxide (CO2)) for
at least 10 min.  To pellet plasmid DNA, the tube was
centrifuged at 10,000 x g for 10 min at 4°C and the
supernatant was removed by pouring off and pulling
remaining excess off with a drawn-out Pasteur pipette.  To
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remove residual salts, 1 ml of -20°C (v/v) 70% EtOH was
added, tube inverted, and then centrifuged for 5 min at
10,000 x g at 4°C.  The supernatant was removed by pouring
off and pulling remaining excess off with a drawn-out
Pasteur pipette, and the pellet was dried for approximately
2-3 min in a Savant Speed Vac Concentrator.  The plasmid
DNA pellet was resuspended by vortexing in 30-40 µl of
sterile ddH2O.  To degrade any RNA present in the sample, 1
µl of RNase A, pre-heated for 5 min in a 65°C water bath,
was added and mixed briefly on a vortex mixer.  After a
brief centrifugation to collect the tube contents at the
bottom of the tube, the tube was placed in a 37°C water bath
for 30 min.  All plasmid DNA was analyzed by agarose
minigel electrophoresis by loading 5 µl of plasmid DNA
combined with 1 µl of 5X Loading Buffer on a 1% agarose gel.
The agarose gel was placed in 1X TAE and electrophoresed a
55 V for approximately 1 h 15 min.  The remaining plasmid
DNA was stored at 4°C.
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Genetic manipulations.
Fill-in reactions, 3’ overhang removal to form blunt
ends or 5’ overhang fill-in to form blunt ends, were
carried out at 12°C for 20 min using T4 DNA polymerase and a
0.2 mM final concentration of dNTPs (New England Biolabs,
Beverly, MA).  Phenol extraction, ether extraction, and
ethanol precipitation followed in order to remove the
polymerase.  Restriction digestions and ligations were
performed according to the specifications of the
manufacturer (New England Biolabs, Beverly, MA).
Agarose minigel electrophoresis.
All DNA fragments, including those from PCR, rapid
plasmid preparations, and restriction enzyme digestions,
were analyzed by agarose gel electrophoresis.  The gel was
prepared by addition of agarose to 1% (w/v) in TAE buffer
(40 mM Tris-Acetate and 1 mM EDTA, pH 8.0).  The components
were swirled to mix, weighed, and then brought to a boil on
a hot stir plate.  Once all the agarose was in solution,
the mixture was allowed to cool briefly and then weighed
again.  Distilled H2O was added to replace the fluid lost by
boiling.  Then 1 µl of 10 mg/ml ethidium bromide (EtBr) was
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added to the gel and allowed to mix for a 1% final gel
concentration.  The gel mix was poured into a gel tray
containing a comb and allowed to cool until solidified.
The comb was then removed.
The gel tray containing the gel was placed in an
electrophoresis chamber containing 1X TAE buffer.  DNA
samples were prepared for loading on the gel by mixing
predetermined amounts of DNA and 5X sample loading buffer
(25% v/v glycerol, 0.5% w/v SDS, 0.1% w/v bromophenol blue,
0.1% w/v xylene cyanol, and 50.0 mM EDTA) and then adding
the mixture to the desired well.  Gels were electrophoresed
for approximately 1 h 15 min at 55 V.  When DNA bands were
hard to visualize, the DNA was stained by placing the gel
in an ethidium bromide solution (0.5 µg ml-1) for 30 min
followed by rinsing and destaining in ddH2O to remove
residual ethidium bromide from the gel.  The gel was then
observed and photographed over UV radiation using a
Fotodyne transilluminator and Polaroid MP-4 camera.
Polaroid type 55 film was used in order to generate
positives as well as negatives, and exposure and
development times were typically 35 s and 25 s,
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respectively.  All negatives were rinsed for 10 min under
tap water before being air-dried.
Purification of DNA fragments.
Immediately following separation of DNA fragments by
agarose gel electrophoresis, DNA bands of interests were
purified by electroelution.  DNA recovery is achieved by
electrophoresis of the DNA from a small slice of
electrophoresis gel into a sealed piece of buffer filled
dialysis tubing.
A razor blade was used in order to excise the slice of
agarose containing the DNA band of interest.  Care was
taken to cut as close to the DNA band as possible.  A 10 mm
dialysis tubing of approximately 6 inches in length was
thoroughly rinsed with distilled H2O both inside and outside
of the tubing and handled with gloves.  A dialysis bag clip
was placed at one end of the tubing and the excised agarose
was placed in the dialysis tubing using a narrow spatula.
Approximately 150 µl of 0.25X TAE buffer was placed inside
the dialysis tubing and the other end of the dialysis
tubing was closed with another dialysis bag clip making
sure no air bubbles were present within the closed dialysis
19
tubing.  The dialysis bag was then placed into a horizontal
agarose gel electrophoresis unit.  The unit was filled with
0.25X TAE buffer until it just covered the dialysis tubing.
A rubber stopper was placed on top of the clips in order to
weigh down the dialysis tubing.  Electroelution then
proceeded for 2 h at 163 V.  Upon completion of
electroelution, the current was reversed for 10 s by
switching the red and black leads.  Using a Fisher brand
micropipette tip, the buffer containing desired DNA was
carefully removed from the bag and placed in a 1.5 ml
microcentrifuge tube.  The gel within the dialysis tubing
was rinsed with 100 µl of 0.25X TAE buffer and transferred
to the microcentrifuge tube.
In order to remove any contaminating proteins, a
phenol extraction was employed.  One volume of water
saturated phenol, pH 8, approximately 250 µl, was added to
the tube under the hood while wearing protective gloves.
The tube was vortexed and then centrifuged at 10,000 x g
for 1 min.  The bottom layer of phenol was then removed
with a drawn-out Pasteur pipette.  This phenol extraction
was repeated once more to insure the extraction of
proteins.
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The following ether extraction was performed twice to
remove the residual phenol.  One volume of ether,
approximately 250 µl, was added to the microcentrifuge tube
under the hood, vortexed briefly, and then centrifuged at
10,000 x g for 10-15 s.  The ether, or top layer, was
removed under the hood with a drawn-out Pasteur pipette.
Next, the tube was centrifuged at 10,000 x g for 10
min to pellet any residual agarose debris.  The supernatant
was transferred to a new microcentrifuge tube with a drawn-
out Pasteur pipette.  The new microcentrifuge tube was
centrifuged at 10,000 x g for 5 min and the supernatant was
again transferred to a new microcentrifuge tube with a
drawn-out Pasteur pipette to ensure agarose debris removal.
The final step was to ethanol precipitate the DNA.
One tenth the volume, about 25 µl, of 3 M sodium acetate and
three volumes, about 750 µl, of 100% cold EtOH were added to
the microcentrifuge tube.  The tube was vortexed and placed
in –80$C freezer or on dry ice for 4-10 min, followed by
centrifugation at 10,000 x g for 10 min at 4°C.  The
supernatant was removed with a drawn-out Pasteur pipette
and discarded.  To remove residual salts, 1 ml of -20°C
(v/v) 70% EtOH was added, tube inverted, and then
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centrifuged for 5 min at 10,000 x g at 4°C.  The supernatant
was removed with a drawn-out Pasteur pipette, and the
pellet was dried for approximately 2-3 min in a Savant
Speed Vac Concentrator.  The DNA pellet was resuspended by
vortexing in 7-30 µl of ddH2O.  For verification of DNA
purity and yield, and analysis of a small quantity of the
eluted fragment by agarose gel electrophoresis was
generally carried out.
Design of mutagenic oligonucleotides.
Oligonucleotide primers for polymerase chain reaction
(PCR) were designed for PCR cloning and PCR site-directed
mutagenesis.  Two primers were designed for each gene
terminus of interest.  A forward primer matched the coding
strand, and a reverse primer was prepared which matched the
complementary strand.  Primers were designed with
restriction enzyme sites to facilitate plasmid cloning.
For the single base mutations, four 24mer oligonucleotides
were designed with the mismatch located at the center (Fig.
6).  The mutagenic oligonucleotides produce a silent
mutation, which does not change the amino acid sequence,
creating an Mlu I restriction enzyme site within the
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conserved carbamoylphosphate domain of the pyrB gene (Fig.
6).  Oligonucleotides were synthesized by Integrated DNA
Technologies, Inc. (Coralville, IA) and Biosynthesis
(Lewisville, TX).  The primer sequences and locations are
detailed in Table 2.
Table 2.  Oligonucleotide primers for PCR.
Primer  Name Description Sequence (5’-3’)
EcBALTF pBEaAS forward primer GAG GCC TCT AGA CTG CAG AAT CAC
Ecmut-40
E. coli pyrB –40 bp upstream
from STRT conserved site
CCA GAG CTG TTG AAG CAC
EcmutM1R
E. coli pyrB reverse
mutagenic primer
GAG GCG GGT ACG CGT AGA GGC TTC
EcmutF
E. coli pyrB forward
mutagenic primer
GAA GCC TCT ACG CGT ACC CGC CTC
EcBALTR pBEaAS reverse primer CAG GAA ACA GGA TCC
PpBAF
P. putida pyrB forward
primer
GCC CTC GAG CGC CAG G
Ppmut-40F
P. putida pyrB –40 bp
upstream from STRT conserved
site
GTC CCG TTG CTG CGC GGC
Ppmut3
P. putida pyrB reverse
mutagenic primer
GGT GCG GGT ACG CGT CGA GTT CTC
Ppmut
P. putida pyrB forward
mutagenic primer
GAG AAC TCG ACG CGT ACC CGC ACC
PpBBR pBpals reverse primer GGC GAA TTC GAG CTC
Polymerase chain reaction.
PCR was performed on DNA fragments ranging from 260 bp
to 1.3 kpb in size.  Taq DNA polymerase was used with
elongation times of 30 s to 1 min, 50 s at 72$C.  The Taq
DNA polymerase was contained in the premixed, double-
concentrated PCR master solution (Boehringer Mannheim,
Indianapolis, IN).  During sample preparation, all reagents
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and reaction mixes were stored on ice.  For a 50 µl total
reaction volume placed in a thin-walled, 0.6 ml PCR tube,
25 µl of PCR master mix was added.  This gives the final
reaction mix 1.25 units of Taq DNA polymerase in 0.005%
(w/v) Brij 35, 0.2 mM each of dATP, dCTP, dGTP, and dDTP,
10 mM Tris-HCl, 50 mM KCl, and 1.5 mM MgCl2.  An additional
0.6 µl of 25 mM MgCl2 was added resulting in an overall
concentration of 1.8 mM MgCl2.  Appropriate volumes of
forward and reverse oligonucleotide primers were added to
give 60 ng of each.  Between 100-300 ng of template DNA
were included in the reaction mix.  The final reaction
volume was achieved by addition of water to give a total of
50 #l.  The sample was layered with an equal volume of
sterile mineral oil to minimize evaporation.
The PCR was performed on an MJ Research PTC-100
Thermal Programmable Controller (MJ Research, Inc.,
Watertown, MA).  Initial denaturation was for 5 min at
94$C, followed by primer annealing for 2 min at a specific
annealing temperature depending on the primers used.
Elongation proceeded for 40 s to 1 min 15 s at 72$C
depending on desired fragment size.  The DNA was again
denatured at 94$C for 2 min.  The sample was cycled through
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the annealing, elongation, and denaturation phases for a
total of 30 times.  After completion of these steps, an
additional elongation period of 5 min was performed.  The
samples were subsequently stored at 4$C.
All products were analyzed by agarose gel
electrophoresis.  A 1.0% (w/v) agarose gel was used for
analysis of PCR products of all fragment sizes.  The
products were typically prepared for loading on the gel by
mixing 10 #l with 2.5 #l of 5X sample loading buffer.
Cloning of PCR products.
Cloning of purified PCR products was achieved using
the TA Cloning Kit dual promoter (Invitogen, Carlsbad, CA).
In order to avoid degradation of the single 3’ A-overhangs
on the PCR products and resulting reduction in ligation
efficiency, ligations were always set up on the same day
that PCR products were generated.  Typically 3-5 µl
(approximately 50-100 ng) of the PCR product was added to a
0.6 ml, thin walled microcentrifuge tube on ice.  Next, 1µl
of 10X Ligation buffer (60 mM Tris-HCl, pH 7.5, 60 mM MgCl2,
50 mM NaCl, 1 mg ml-1 bovine serum albumin, 70 mM β-
mercaptoethanol, 1 mM ATP, 20 mM dithiothreitol, 10 mM
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spermidine), 2 µl of pCR%II vector (25 ng µl-1), and sterile
water to a total volume of 9 µl were included in the PCR
tube.  The addition of 1 µl of T4 DNA Ligase (4.0 Weiss
units) brought the total ligation reaction volume to 10 µl.
The ligation reaction was incubated at 14°C for 16 h in an
MJ Research PTC-100 Thermal Programmable Controller.
Transformation was achieved by adding the entire 10 µl
ligation reaction into 200 µl of competent E. coli DH5α in
a 1.5 ml microcentrifuge tube.  The mixture was incubated
on ice for 20 min and then heat shocked in a 42°C water bath
for 2 min.  The mixture was then diluted with 1 ml of LB
broth and incubated for 1 h with shaking at 250 rpm at 37°C.
During this incubation period, 50 µl of 2% 5-bromo-4-chloro-
3-indolyl β-D-galactopyranoside (X-gal) and 10 µl if 100 mM
isopropylthiogalactoside (IPTG) were added to three LB agar
+ Ampicillin (Amp, 100 µg ml-1) plates per ligation with a
sterile spreader.  These LB plates were then placed in a
37°C incubator for 30 min to allow the added reagents to
dry.
Following the 1 h incubation, 100 µl and 20 µl of the
transformed cells were plated onto two different LB + Amp +
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X-gal + IPTG plates using a sterile spreader.  The
remaining transformed cells were pelleted by centrifugation
at 10,000 x g for 4-5 s.  The supernatant was poured off
and the pellet was resuspended in the remaining drop by
brief mixing with a vortex mixer.  The resuspended cells
were then plated onto the remaining LB + Amp + X-gal + IPTG
plate.  These plates were then incubated at 37°C for 16 h to
24 h.
The pCR%II vector contained an ampicillin resistance
gene, thus allowing transformed cells to grow in
ampicillin.  Fifteen white colonies (containing E. coli
DH5α with pCR%II vector + insert) and one blue colony
(containing E. coli DH5α with pCR%II vector only), selected
to serve as a control, were selected from the
transformation plates and inoculated into 5 ml LB broth
containing Amp (100 µg ml-1) by using sterile toothpicks.
The transformed cells were incubated 12 h to 24 h at 37°C
with shaking at 250 rpm.
Analysis of plasmid DNA by restriction enzyme digestion.
To determine which plasmids had inserts of the desired
size, a restriction enzyme digestion was employed in order
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to remove the insert from the pCR%II vector.  The
restriction enzyme, EcoRI (New England Biolabs, Beverly,
MA), was chosen based on the fact that it has only two cut
sites in the pCR%II vector, which reside on either side of
the insert.  Therefore, EcoRI digestions of plasmid DNA
should produce only two bands, 3.9 kbp for the vector and
the desired length for the insert, when separated by
agarose gel electrophoresis.
To set up a restriction enzyme digest, the following
contents were added to a 0.6 ml microcentrifuge tube: 4-5 µl
of plasmid DNA isolated by alkaline lysis, 1 µl of EcoRI
restriction enzyme, 2 µl of 10X EcoRI buffer (50 mM NaCl,
100 mM Tris-HCl, 10 mM MgCl2, 0.025% Triton X-100, pH 7.5 @
25°C), and ddH2O up to a total volume of 20 µl.  The
contents were then incubated in a 37°C water bath for 2 h,
followed by heat inactivation of the EcoRI in a 65°C water
bath for 20 min.  The EcoRI digest was then analyzed by
loading a combination of 20 µl of the EcoRI digest and 5 µl
of 5X Loading Buffer on a 1% agarose gel placed in 1X TAE.
The sample was electrophoresed at 55 V for 1 h 15 min.
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Preparation of plasmid DNA for sequencing.
After plasmid analysis by restriction digestion,
plasmids believed to be a desired clone were further
purified for double stranded (ds) DNA sequencing.  Of the
remaining 3.5 ml of the desired overnight culture
previously used for isolation of plasmid DNA by alkaline
lysis, 10 µl was removed and used to inoculate 10 ml of LB
broth containing freshly added antibiotic of the
appropriate kind and amount.  This culture was incubated
for 16-24 h at 37°C with shaking at 250 rpm.
Plasmid DNA was purified from this culture using the
RPM Spin Midi Kit and protocol (BIO 101, Inc., La Jolla,
CA).  Specific reagents included in each solution were not
available from BIO 101.  The 10 ml LB broth culture was
transferred to a 15 ml sterile centrifuge tube and
harvested by centrifugation in a RT6000B Refrigerated
Centrifuge for 10 min at 4°C in a Sorvall H1000B rotor at
1800 x g.  The supernatant was poured off, and the pellet
was resuspended in 500 #l of sterile ddH2O by vortex.  Cells
were transferred to a 2 ml microcentrifuge tube and
centrifuged at 10,000 x g for 20 s.  Again the supernatant
was poured off.  The supernatant was poured off and the
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remaining excess pulled off with a drawn-out Pasteur
pipette.  At this stage, the cell pellet was either stored
at –20°C until ready to process or used immediately.  Those
pellets that were stored at –20°C were first thawed for 8
min at 37°C before continuing with the following plasmid
purification.
Plasmid DNA isolation and purification began with the
addition of 200 µl of Pre-Lysis Solution.  The bacterial
pellet was completely resuspended in this solution by
mixing on a vortex mixer.  Next, 400 µl of Alkaline Lysis
Solution was added, and the tube was inverted gently 15
times.  Following this, 300 µl of ice-cold Neutralizing
Solution was added, and the tube was shaken vigorously 3-5
times until a uniform white precipitate formed.  The tube
was then centrifuged for 5 min at 10,000 x g, and the
supernatant was carefully transferred to a new 2 ml
microcentrifuge tube.
GLASSMILK Spin Buffer containing a silica matrix was
incubated for 10 min in a 65°C water bath, and then 900 µl
of this Spin Buffer was added.  The tube was inverted
gently for 5 min at room temperature and then centrifuged
for 5 s at 10,000 x g at room temperature.  The supernatant
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was decanted, leaving the plasmid DNA bound to the
GLASSMILK, and 500 µl of Wash Solution containing EtOH was
added.  The GLASSMILK/plasmid DNA complex was resuspended
by gentle pipetting up and down, and the solution was then
transferred to a kit-supplied SPIN Filter.  This filter was
centrifuged for 20 s at 10,000 x g to separate the
GLASSMILK/plasmid DNA complex from the Wash Solution.  The
Catch Tube containing the Wash Solution was emptied and the
Spin Filter reassembled.  A second wash was performed by
adding an additional 500 µl of Wash solution and
recentrifuging for 5 min at 10,000 x g to dry the
GLASSMILK/plasmid DNA complex trapped by the Spin Filter.
The Spin Filter was then transferred to a new kit-supplied
Catch Tube, and 100 µl of Elution Solution containing Tris-
HCl and EDTA was added to remove the plasmid DNA from the
GLASSMILK.  The plasmid DNA was eluted by gently stirring
and pipetting the solution up and down with a 200 µl pipette
until the GLASSMILK/plasmid DNA complex was completely
resuspended.  The Catch Tube was then centrifuged at 10,000
x g for 5 min to collect the eluted DNA in the Catch Tube.
The Spin Filter containing the GLASSMILK was discarded.
The eluted plasmid DNA was analyzed by agarose minigel
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electrophoresis by loading a combination of 5 µl of the
eluted plasmid DNA with 1 µl of 5X Loading Buffer on a 1%
agarose gel in 1X TAE.
Double stranded DNA sequencing.
In order to verify the genetic makeup of the clones
created, the plasmids were analyzed by double stranded DNA
sequencing using the dideoxyribonucleotide method of chain
termination (Sanger et al., 1977).  Sequencing reactions
were set up according to a slight modification of the
protocol provided for the T7 Sequenase version 2.0 DNA
sequencing kit (Amersham Life Science, Inc., Cleveland,
OH).  For each plasmid to be sequenced, both M13 Forward
(-40) and M13 Reverse primers were utilized, thus allowing
sequence to be read from opposite ends of the insert.
Approximately 5 µg of plasmid DNA was placed into a 1.5 ml
microcentrifuge tube, and ddH2O was added to achieve a total
volume of 30 µl.  To denature the DNA, 3 µl of freshly
prepared 2 N NaOH was added, and the mixture was incubated
at room temperature for 5 min.  Next, 120 µl of –20°C 100%
EtOH was added along with 5 µl of 3 M sodium acetate, pH
5.0.  This was mixed and incubated at –78.5°C in solid CO2
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for 5 min.  This was then centrifuged at 10,000 x g for 20
min at 4°C.  The supernatant was removed without disturbing
the pellet using a siliconized, drawn-out Pasteur pipette.
To remove residual salts, 200 µl of –20°C 70% EtOH was
added, and the tube was centrifuged for 5 min at 10,000 x g
at 4°C.  The supernatant was again removed with a
siliconized, drawn-out Pasteur pipette.  This 70% EtOH wash
was repeated, and the pellet was dried for 3-5 min in a
Savant Speed Vac Concentrator.  The pellet was resuspended
in 7 µl ddH2O with two freeze-thaw cycles consisting of
incubation of the tube at –78.5°C in solid CO2 for 10 min
followed by a 5 min incubation in a 65°C water bath.
Following each 65°C incubation, the plasmid DNA and ddH2O
were mixed with a vortex mixer and centrifuged at 10,000 x
g for 4 s to collect the mixture at the bottom of the tube.
Following this initial denaturation and cleanup, 2 µl
of T7 Sequenase Reaction Buffer (200 mM Tris-HCl, pH 7.5,
100 mM MgCl2, and 250 mM NaCl) from the T7 Sequenase Kit was
added along with 1 µl of either M13 Forward (-40) or M13
Reverse primers (0.5 pmol µl-1).  Incubation at 37°C for 45
min allowed the primer to anneal to the template.  After
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placing this tube on ice, four 0.5 ml tubes were labeled
and filled with 2.5 µl of the appropriate termination mix
(80 µM dGTP, 80 µM dCTP, 80 µM dTTP, 50 mM NaCl, and 8 µM of
the appropriate ddNTP) from the red-capped tubes from the
T7 Sequenase Kit.  The termination tubes were stored on ice
until use.  In another 0.5 ml tube, a 1:5 diluted labeling
mix was prepared, usually by adding 2 µl of the T7 Sequenase
dGTP Labeling Mix (7.5 µM dGTP, 7.5 µM dCTP, and 7.5 µM
dTTP) from the green-capped tube to 8 µl of ddH2O.  The 1:5
Labeling Mix was stored on ice.  Diluted T7 Sequenase DNA
polymerase was prepared in a separate 0.5 ml tube by adding
the following components on ice, all from the T7 Sequenase
Kit: 1.2 µl of inorganic pyrophosphatase (5 U ml-1 in 10 mM
Tris-HCl, pH 7.5, 0.1 mM EDTA, and 50% v/v glycerol), 7.2 µl
of glycerol enzyme dilution buffer (20 mM Tris-HCl, pH 7.5,
2 mM DTT, 0.1 mM EDTA, and 50% v/v glycerol), and 1.2 µl of
T7 Sequenase version 2.0 DNA polymerase (13 U µl-1 in 20 mM
KPO4, pH 7.4, 1 mM DTT, 0.1 mM EDTA, and 50% v/v glycerol).
The four termination tubes were then pre-warmed in a
39°C heating block.  The following components were added to
the ice-cold annealed DNA mixture: 1 µl of 0.1 M
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Dithiothreitol (DTT from the T7 Sequenase Kit), 2 µl of the
1:5 Labeling Mix, 1 µl of Dimethylsulfoxide (DMSO), 0.5 µl
of Redivue [α-35S] dATP (12.5 µCi µl-1), and 2 µl of diluted
T7 Sequenase DNA Polymerase.  This mixture was centrifuged
at 10,000 x g for 3 s.  To allow chain termination to
occur, 3.5 µl of the labeling reaction mixture was added to
each of the four termination tubes and incubated for 20 min
at 39 °C.  Next, 4 µl of Stop solution (95% formamide, 20 mM
EDTA, 0.05% bromophenol blue, and 0.05% xylene cyanol FF)
from the T7 Sequenase Kit was added to each termination
tube and mixed by pipetting up and down.  The tubes were
then centrifuged at 10,000 x g for 3 s and frozen at –20 °C.
Some DNA sequence reactions were performed and
provided by ACGT, Inc. (Northbrook, IL).
Preparation of polyacrylamide sequencing gels.
A gel cassette was assembled to provide a reservoir
for the sequencing gel.  The sequencing plates measured
50.8 cm x 40.6 cm and were cleaned twice with glass cleaner
followed by 100% EtOH.  The inside of the notched plate was
siliconized with chlorinated organopolysiloxane in heptane
to prevent the gel from adhering to this plate.  The
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outside of the non-notched plate had a thermometer so that
the temperature of the gel could be regulated.  After
adding spacers to the long dimensions of one plate, the
other gel plate was positioned on top of the plate with the
spacers, and all of the sides except for the top were taped
together.
All samples were analyzed on a 6% polyacrylamide
sequencing gel prepared by mixing the following components
in a 250 ml beaker: 42.4 g of urea, 20 ml of a 29%
acrylamide/1% bis-acrylamide mixture stored at 4°C, and 10
ml of 10X TBE sequencing buffer (890 mM Tris base, 890 mM
boric acid, and 20 mM EDTA).  These first three ingredients
were stirred and heated until they dissolved, and then ddH2O
was added up to 100 ml.  The mixture was again stirred
until it dissolved completely.  Undissolved particles were
removed from the solution by filtering it through a Buchner
funnel containing a piece of Whatman No. 50 filter paper,
and the filtrate was collected in a 250 ml Erlenmeyer
vacuum filtration flask.  Next, 0.12 g of solid ammonium
persulfate was added and the solution swirled to mix.
After covering the flask with a rubber stopper, the
solution was degassed in vacuo until all gasses were
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removed (about 3-5 min), and the contents were then
carefully poured into a 250 ml beaker.
Immediately before pouring the solution into the gel
cassette, 20 µl of N, N, N’, N’ -Tetramethylethylenediamine
(TEMED) was added, and the solution was briefly stirred
with a stir bar and magnetic stirrer.  The gel was then
poured by pulling up 60 ml of the solution into a 60 cc
syringe and then slowly and steadily discharging the
solution into one corner of the gel plates, which had
previously been set at a 45° angle.  The gel cassette was
then placed on rubber stoppers in a horizontal position,
and the comb was inserted with its teeth flush with the
outside edge of the plate.  Clamps were placed over the two
plates at the level of the comb in order to prevent
movement of the comb, and plastic wrap was used to cover
the open end of the plate to prevent the gel from drying
out.  The gel was allowed to polymerize for a minimum of 3
h (preferably overnight).
Loading and electrophoresing the sequencing gel.
After allowing the gel to polymerize, the shark’s
tooth well-forming comb and the tape holding the two plates
together were removed.  The plates holding the gel were
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then placed into the gel chamber apparatus, and 1X TBE
buffer (89 mM Tris base, 89 mM boric acid, and 2 mM EDTA)
was added to the upper and lower chambers.  Air bubbles
were removed from the bottom of the gel cassette, and the
well-forming comb was inserted with the shark’s teeth
facing the top of the gel.  A 60 cc syringe was used to
eject 1X TBE at the top surface of the gel in order to
remove any debris that was present.  In order to warm up
the plates to prevent renaturation of DNA, the gel was pre-
electrophoresed for 1 h at 72 W (approximately 1600 V)
after adding 2 µl of Stop solution to one of the outer
wells on each side of the gel.
Once the plates had reached a temperature of 50-55°C,
the power supply was turned off, and a needle and syringe
was used to wash out each of the wells to be used with 1X
TBE.  Samples to be loaded were first denatured at 90°C for
2 min followed by a 5 min quick cool on ice.  Next, 3 µl of
sample was loaded in each well with the order from left to
right always being GATC.  Samples were electrophoresed at
72 W (approximately 1600 V) until the xylene cyanol dye had
migrated a distance of 30 cm.  The same samples were then
reloaded, and the xylene cyanol was allowed to migrate 60
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cm.  The 60 cm run allowed sequence to be read further into
the insert.  Longer runs were employed when necessary.
Following completion of electrophoresis, the power
supply was turned off, the plates were removed from the
sequencing chamber and placed on the bench top, and the
siliconized, notched plate was separated from the gel using
a spatula.  A 43 cm x 35 cm piece of Whatman 3 MM paper was
placed on top of the gel, and a pipette was rolled on top
of the Whatman paper to allow the gel to adhere to the
Whatman paper.  The Whatman paper, with gel adhered, was
placed gel side up on the bench top, and the gel was
covered with plastic wrap.  The gel was dried for 3 h at
76°C in a Drygel Sr. Slab Gel Dryer Model SE 1160 supplied
by Hoefer Scientific Instruments (San Francisco, CA)
attached to a Savant refrigerated solvent trap.
Autoradiography of sequencing gels.
After the sequencing gel was dried completely, the
Saran wrap was removed, and the gel adhered to Whatman
paper was placed in a Fisher Biotech metal cassette with
the gel side facing up.  The number of counts min-1 was
measured using a W. B. Johnson GSM-5 Survey Meter (Mountain
Lakes, NJ) in order to determine the exposure time.  In a
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dark room, Kodak XAR-5 film was placed in a dark drawer to
expose the film for approximately 72-120 h.  The film was
developed using an All Pro 100 developer.
Nondenaturing polyacrylamide activity gels.
Cell extract was prepared as described previously for
the ATCase activity assay.  Samples of typically 24 µl of
cell extract were mixed with 6 µl of 5X loading buffer
(312.5 mM Tris, pH 6.8, 50% v/v glycerol, and 0.05% w/v
bromophenol blue in ddH2O).  The total volume of 30 µl was
loaded onto a nondenaturing polyacrylamide gel (PAGE) with
a 5% stacking gel and an 8% separating gel.  Partially
purified ATCase from E. coli K12 (holoenzyme and catalytic
trimer) and P. aeruginosa PAO1 with known molecular mass
were used as standards.  The gel was run in a Bio-Rad Mini-
Protean II cell at 100 V for 2.5 h at room temperature.
The gel was prepared by first pouring the separating gel,
which contained 2.67 ml of the stock solution of acrylamide
(29% w/v acrylamide and 1% w/v bis-acrylamide in ddH2O),
2.5 ml of Buffer B (1.5 M Tris-HCl, pH 8.8), and 4.83 ml of
ddH2O.  Ammonium persulfate (0.02 g) was added to the
mixture to remove dissolved oxygen.  Just prior to pouring
the gel, 5 µl of N, N, N', N' - tetramethylethylenediamine
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(TEMED) was added and mixed in by gentle inversion.  The
solution was poured into the gel plates leaving a 2 cm gap
at the top.  The separating gel was covered with a layer of
N-butanol to prevent drying and allowed to stand at room
temperature for 1 h to polymerize.  The butanol layer was
poured off, and the stacking gel poured.  The stacking gel
contained 0.67 ml of the stock solution of 30% acrylamide,
1 ml of Buffer C (0.5 M Tris, pH 6.8), and 2.3 ml of ddH2O.
Ammonium persulfate (0.01 g) and TEMED (5 µl) were added.
Once the stacking gel was poured, a comb was inserted
between the plates to form the wells.  The stacking gel was
allowed to polymerize for 30 min.  The running buffer
contained 25 mM Tris and 192 mM glycine in ddH2O at a pH of
8.8.
The gels were stained specifically for ATCase activity
by a procedure developed by Bothwell (Bothwell 1975) and
further modified by K. Kedzie (1987), who used histidine
instead of imidazole.  In this study, one slight
modification to the procedure were made as indicated.  When
the electrophoresis was complete, the plates were
separated, and the gel was placed in 250 ml 50 mM
histidine, pH 7.0, at 4°C, for 5 min while gently shaking.
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After this equilibration, 5 ml of 1 M aspartate and 10 ml
of 0.1 M carbamoylphosphate were added to the gel and
allowed to react for 20 min (modified to extend time from
10 min to allow resolution of faint bands).  The gel was
rinsed 3 times with ice-cold ddH2O to remove the reactants.
Orthophosphate released enzymatically and trapped in the
gel was precipitated by the addition of 3 mM lead nitrate
in ice-cold 50 mM histidine, pH 7.0.  Lead nitrate was
removed after 10 min with 3 changes of ice-cold ddH2O.
ATCase activity was visible as white bands at the site of
lead phosphate precipitation.  Intensity of the bands
generally increased with storage overnight at 4°C in ddH2O.
For better visualization of the bands, the gels were
sometimes stained with 1% sodium sulfide for 3 min.  Brown
lead sulfide then replaced the white lead phosphate bands.
The gel was destained in ddH2O to remove background.  
To retain the gels in a permanent form, they were
preserved by drying between two sheets of Promega gel
drying film while suspended between a Promega gel drying
frame.  After placing in the apparatus, they were allowed
to dry at room temperature overnight.  The dried gel was
removed from the frame and excess drying film removed from
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Clones pBEaAS and pBpals.
In preparation for site directed mutagenesis, two
clones were constructed, E. coli pyrB and P. putida pyrB
cloned into the pALTER®-Ex1 vector. The plasmid naming
scheme for pBEaAS is as follows: plasmid, pyrB, E. coli,
pALTER®-Ex1, Jesus Arroyo (researcher), and Luci Simpson.
The plasmid naming scheme for pBpals is as follows:
plasmid, pyrB, P. putida, pALTER®-Ex1, Luci, and Simpson.
Plasmid pBEaAS (Fig. 7), which carries the pyrB of E. coli
in pALTER®-Ex1, was constructed by restriction endonuclease
digestion of pBJR28 and pALTER®-Ex1 with BamHI and PstI
followed by ligation (Fig. 8).  Plasmid pBpals (Fig. 9),
which carries the pyrB of P. putida in pALTER®-Ex1, was
constructed by restriction endonuclease digestion of pAK10
and pALTER®-Ex1 with EcoR1 and HindIII followed by ligation
using T4 DNA ligase (Fig. 10).  These ligated mixtures were
then transformed into competent E. coli DH5" cells followed
by selection on LBamp100 plates.  Restriction enzyme
digestion and DNA sequencing (Sanger et al., 1977) across
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the vector-insert junctions (Figs. 11 & 12) have verified
these constructs.
Restriction endonuclease digestion of pBEaAS with
BamHI and PstI produced two DNA fragments, one of
approximately 5.8 kbp in size, which represents the linear
pDNA of the vector, pALTER-Ex1, and the other of
approximately 1.4 kbp in size, representing the insert DNA
of E. coli pyrB (Fig. 11).  Restriction endonuclease
digestion of pBpals with EcoRI and HindIII produced two DNA
fragments, one of approximately 5.8 kbp in size, which
represents the linear pDNA of the vector, pALTER-Ex1, and
the other of approximately 1 kbp in size, representing the
insert DNA of P. putida pyrB (Fig. 11).
Sequencing across the insert-vector junction of pBEaAS
using both M13 Forward and M13 Reverse sequencing primers
verified the presence of E. coli pyrB from pBJR28 within
the pALTER-Ex1 vector in orientation identical to that of
the T7 promoter.  Sequencing across the insert-vector
junction of pBpals using both M13 Forward and M13 Reverse
sequencing primers verified the presence of P. putida pyrB
from pAK10 within the pALTER-Ex1 vector in orientation
identical to that of the tac promoter.  These nucleotide
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sequences were compared to known sequence using the NCBI
BLAST algorithm tool (Altschul et al., 1997) and are shown
in Figure 12.  Clones pBEaAS and pBpals were originally
created in order to perform site-directed mutagenesis
utilizing the pALTER&-Ex1 system.  Attempts made using the
pALTER&-Ex1 system produced no results.  A change in
strategy was developed and these clones were used to
perform PCR site-directed mutagenesis instead.
Clone pBJR28.
Sequencing across the insert-vector junction of pBJR28
using both M13 Forward and Reverse sequencing primers
clarified the exact identity and orientation of the insert
DNA.  This sequence was compared to known sequence using
the NCBI BLAST algorithm tool and is shown in Figure 18.
The sequence comparison found a partial section of pyrI to
be inverted.  From this sequence a detailed plasmid map of
pBJR28 was constructed (Fig. 19).
Clone pAK10.
Sequencing across the insert-vector junction of pAK10
using both M13 Forward and Reverse sequencing primers
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clarified the exact identity and orientation of the insert
DNA.  This sequence was compared to known sequence using
the NCBI BLAST algorithm tool and is shown in Figure 20.
From this sequence a detailed plasmid map of pAK10 was
constructed (Fig. 21).
Clones pNELLS, pCELLS, pNPS, and pCPS.
In order to construct hybrid genes, an MluI
restriction enzyme site was introduced at the
carbamoylphosphate binding site within the pyrB genes of
both E. coli and P. putida.  This silent mutation was
created by site-directed mutagenesis using PCR, which was
also used to amplify all four domains individually (polar
and equatorial domains of both E. coli and P. putida) and
in so doing created a Mlu I restriction enzyme site in all
four products.  The original clones used for site-directed
mutagenesis were pBEaAS and pBpals.  The PCR product was
then cloned into the PCR vector pCRII.  These four clones
were named pNELLS (plasmid, N-terminus, E. coli, Layman
(researcher), Luci Simpson), pCELLS (plasmid, C-terminus,
E. coli, Layman (researcher), Luci Simpson), pNPS (plasmid,
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N-terminus, P. putida, Simpson), and pCPS (plasmid, C-
terminus, P. putida, Simpson).
Clones pNELLS and pCELLS (Fig.13) were created by PCR
amplification of the desired E. coli pyrB terminus using
pBEaAS as the template DNA.  Amplification of the N-
terminus for the construction of pNELLS was performed using
oligonucleotides EcBALTF and ECBmutM1R, an annealing
temperature of 44°C, and an elongation time of 1 min.
Amplification of the C-terminus for the construction of
pCELLS was performed using oligonucleotides EcBmutF and
EcBALTR, an annealing temperature of 39°C, and an elongation
time of 1 min. 15 s.
Clones pNPS and pCPS (Fig. 14) were created by PCR
amplification of the desired P. putida pyrB terminus using
pBpals as the template DNA.  Amplification of the N-
terminus for the construction of pNPS was performed using
oligonucleotides PpBAF and Ppmut3, an annealing temperature
of 60°C, and an elongation time of 40 s.  Amplification of
the C-terminus for the construction of pCPS was performed
using oligonucleotides PpBBR and Ppmut, an annealing
temperature of 45°C, and an elongation time of 1 min 15 s.
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These PCR products were then ligated into the pCRII
cloning vector and analyzed by EcoRI restriction enzyme
digestion.  Restriction endonuclease digestion of pNELLS,
pCELLS, pNPS, and pCPS with EcoRI produced two DNA
fragments, one of approximately 3.9 kbp in size,
representing the linear pDNA of the vector, pCRII, and the
other ranging from 260 bp to 1.06 kbp, representing the
insert DNA of each clone (Fig. 15).
Confirmation of the mutagenic site was shown by MluI
digests (Fig. 15) and DNA sequencing (Figs. 16 and 17).
Restriction endonuclease digestion of pNELLS, pCELLS,
pNPS, and pCPS with MluI produced one DNA fragment for each
clone ranging from 4.16 to 4.95 kbp in size representing
linearized pDNA of the vector plus insert.  The sizes of
the DNA fragments differed depending on the insert size of
each clone (Fig. 15).
Sequencing across the insert-vector junction of
pNELLS, pCELLS, pNPS, and pCPS using both M13 Forward and
M13 Reverse sequencing primers verified the presence of the
insert DNA and the MluI restriction enzyme site in each of
the four clones (Fig. 16).  Sequence identified the insert
DNA of pNELLS and pCELLS, N-terminus and C-terminus of E.
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coli pyrB, to be in orientation identical to that of the
Lac promoter.  Sequence identified the insert DNA of pNPS
and pCPS, N-terminus and C-terminus of P. putida pyrB, to
be in orientation opposite to that of the lac promoter.
These nucleotide sequences were compared to the known
sequence using the NCBI BLAST algorithm tool and are shown
in Fig. 17.
Clones pNELLS, pCELLS, pNPS, and pCPS are cassette
systems, which can be utilized to create intergeneric
hybrid ATCases.  Such hybrid ATCases are useful in the
study of the relationship of function and structure with
genetic regions and domains from different genera or
species.  Clones pNPS and pCELLS could be used to create a
P. putida-E. coli hybrid pyrB.  This hybrid gene could then
be used to test the hypotheses described earlier.
Typically, the hybrid gene would be transformed into E.
coli strain TB2, with no ATCase activity, to test for
complementation.  Failure to complement would suggest that
the N-terminal region of P. putida pyrB prohibits formation
of a trimer as it does in P. putida wild type.
Complementation would indicate that an active ATCase can be
produced.
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The size of the hybrid ATCase could then be determined
on a native non-denaturing PAGE and stained for activity.
The hybrid ATCase could be purified from E. coli cells
containing the plasmid insert, and kinetics performed on
the enzyme.  An intact E. coli trimer is active but not
regulated.  Based on work in our laboratory, the N-terminal
region of the P. putida PyrB polypeptide contains the
effector binding site.  The active hybrid ATCase
(presumably a trimer) could be tested for regulation with
effector molecules, ATP, CTP, and UTP.  If regulation were
observed, this would further confirm our finding on the
effector binding site.
The same hybrid pyrB could also be cotransformed with
an E. coli pyrI on a compatible plasmid to determine if an
E. coli-like dodecamer is formed.  If dodecamer formation
is possible, then this enzyme could be tested for
inhibition by UTP, CTP, and activation by ATP.  The native
E. coli holoenzyme is not inhibited by UTP alone.  Wild
type E. coli ATCase holoenzyme displays sigmoidal kinetics
when velocity-substrate plots are made.  ATP activation and
CTP inhibition are also seen.  It would be interesting to
learn if the hybrid holoenzyme maintained similar kinetics.
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Clones pNELLS and pCPS were used to create an E. coli-
P. putida hybrid pyrB described below.
Clone pBEP.
In order to test the hypotheses, an intergeneric
hybrid pyrB gene was constructed between E. coli and P.
putida.  The plasmid naming scheme for pBEP is as follows:
plasmid, pyrB, E. coli, and P. putida.  Plasmid pBEP (Fig.
22), which carries the E. coli polar domain of pyrB and the
P. putida equatorial domain of pyrB was constructed by
manipulation of pNELLS and pCPS.  First, pNELLS was cut
with restriction enzyme MluI and EcoRV, which opens up or
linearizes the vector DNA.  Second, pCPS was similarly cut
with restriction enzyme KpnI followed by a fill-in reaction
to create a blunt end for compatability with EcoRV.  Third,
pCPS was double digested with MluI and NotI.  This double
restriction enzyme digestion performed two different
functions.  The MluI digest cut out the insert DNA of pCPS
and allowed for compatability with the vector DNA, while
the NotI digest helped to prevent the vector DNA of pCPS
from ligating into the linear pNELLS vector by creating
incompatible ends.  Finally, the two digested clones were
ethanol precipitated followed by a 20:1 insert to vector
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ligation using T4 DNA ligase (Fig. 23).  The ligated
mixture was then transformed into competent E. coli TB2
cells followed by selection on LBamp100 plates.  EcoRI and
MluI restriction enzyme digestion has verified this
construct (Fig. 24).
Restriction endonuclease digestion of pBEP with EcoRI
produced two DNA fragments, one of approximately 3.9 kbp in
size, which represents the linear pDNA of the vector,
pCR%II, and the other of approximately 1.6 kbp,
representing the insert DNA of E. coli-P. putida pyrB (Fig.
24).  Restriction endonuclease digestion of pBEP with EcoRI
and MluI produced three DNA fragments, one of approximately
3.9 kbp in size, representing the linear vector DNA, one of
approximately 820 bp in size, which represents the P.
putida equatorial domain DNA fragment of pyrB, and one of
approximately 440 bp in size, which represents the E. coli
polar domain DNA fragment of pyrB (Fig. 24).
The creation of the E. coli-P. putida hybrid pyrB
enables the study of the N-terminal extension of P. putida
pyrB.  This clone allows for the determination of whether
the N-terminus of the P. putida PyrB polypeptide precludes
assembly of an ATCase trimer and thus inhibits ATCase
function.
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The pBEP clone was transformed into the same E. coli
strain TB2 and analyzed for complementation.  Growth of the
transformants in Ecmm medium at 30°C indicates that an
active trimer was assembled.  Cell extracts were run on a
non-denaturing PAGE gel stained for ATCase activity
(Foltermann, 1986)(Fig. 25).  The pBEP clone produced a 100
kDa catalytic trimer.  This result strongly suggests that
the N-terminal region of P. putida PyrB prevents the
formation of an active trimer, as seen in P. putida wild
type PyrB.  Our lab has shown that the Pseudomonas pyrB
gene encodes a polypeptide that exists only as monomers
(Kumar et al. 1999).
The pBEP clone can also be used to determine if the N-
terminus region of P. putida PyrB participates in binding
nucleotide effectors for the purpose of regulation of
ATCase activity.  This could be achieved by
cotransformation of pBEP with pDBPC' (a P. putida pyrC'
which lacks the P. putida pyrB clone).  If regulation is
not found for the holoenzyme formed from the
cotransformation of pBEP with pDBPC', then this would
further confirm the regulatory function of the N-terminus
region of P. putida PyrB.  To date the only information we
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have on the Pseudomonas PyrC' polypeptide is that it is
required for assembly into a dodecamer and to provide
structural stability (Kumar et al., 1999).  If regulation
is observed for the hybrid holoenzyme, then a function for
the Pseudomonas PyrC' polypeptide would be discovered.
Since the E. coli-P. putida pyrB gene contains the E.
coli upstream promoter-leader sequence, it could be tested
in TB2 for repression of this active hybrid ATCase even
though the gene is mainly Pseudomonas.  To date, only two-
fold repression is observed in Pseudomonas.  Another
advantage of this repressible pyrB gene would be for
cotransformation with the Pseudomonas pyrC' gene, pDBPC',
to see if a 480 kDa holoenzyme is formed.  The proportion
of PyrB: PyrC' could also be tested.  Knowing this ratio is
important in studies of assembly into a dodecamer.
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 Figure 1.  Pyrimidine biosynthetic pathway in Escherichia
coli and Salmonella typhimurium.  Gene symbols and the
enzymes they encode are: ndk – nucleoside diphosphate
kinase; pyrA (carAB) – carbamoylphosphate synthetase; pyrBI
– aspartate transcarbamoylase; pyrC – dihydroorotase; pyrD
– dihydroorotate dehydrogenase; pyrE – orotate
phosphoribosyltransferase; pyrF - OMP decarboxylase; pyrG –























Figure 2.  Classes of bacterial ATCase (not drawn to scale).  Adapted from
Bergh & Evans (1993).
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Figure 3. Assembly of ATCase holoenzyme from E. coli and P. putida
(not drawn to scale).
 E. coli pyrB
encodes a 34 kDa 
polypeptide that 
assembles into an 
active, not 
regulated trimer.
 P.putida pyrB 
 encodes a 36 kDa 
polypeptide that 
assembles into an 
inactive trimer.
Figure 4. Assembly of PyrB from E. coli and P.
putida.  Rectangular bars represent DNA genes and
circles represent the polypeptides encode by the
genes.
Figure 5. Assembly of PyrB from E. coli and P. putida.
Blue lines represent PyrB polypeptides encoded by pyrB.
 
 P. putida PyrB
 assembled into trimer form
 E. coli PyrB 
assembed into trimer form
No 
Activity
Black represents 11 amino acid overhang
P. putida  PyrB
Activity
E. coli  Pyr B
Figure 6.  Mutagenic Oligo Design.  MluI restriction
enzyme sequence is indicated in purple.  Standard single
letter codes for bases are adenosine (A), cytidine (C),
guanosine (G), and thymidine (T).  Single letter codes
for the amino acids are serine (S), threonine (T), and
arginine (R).
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+ ligation
Figure 8.  Schematic diagram demonstrating the genealogy of pBEaAS.
Figure 9.  pBpals plasmid map.
pBpals


























Figure 10.  Schematic diagram demonstrating the genealogy of pBpals.
Figure 11.  An agarose gel depicting restriction enzyme digestion
of pBEaAS and pBpals.







Lane 1 and 6.  Lambda DNA - HindIII Digest DNA size marker.
Lane 2 and 3.  Undigested pBEaAS.
Lane 4 and 5.  Undigested pBpals.
Lane 7 and 8.  BamHI and PstI digestion of pBEaAS - ~5.9 kbp linear vector,
     ~1.47 kbp insert DNA.
Lane 9 and 10.  EcoRI and HindIII digestion of pBpals - ~5.9 kbp linear vector,
      ~1.43 kbp insert DNA.
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Figure 12. Insert-vector junction DNA sequence comparison
of pBEaAS and pBpals with known E. coli pyrBI, P. putida
pyrB, and pALTER-Ex1 cloning vector sequences.  The E.
coli, P. putida, and pALTER-Ex1 sequences were obtained
from GenBank and are available on the Internet at
http://www.ncbi.nlm.nih.gov.  Query A is the M13 Forward
primer pBEaAS sequence read from a DNA sequencing
polyacrylamide gel.  Subject A is the E. coli pyrBI operon
encoding for ATCase with a length of 1593 bp.  Query B is
the M13 Reverse primer pBEaAS sequence read from a DNA
sequencing polyacrylamide gel.  Subject B is the cloning
vector pALTER-Ex1 complete vector sequence of 5858 bp.
Subject C is the E. coli pyrBI operon encoding ATCase with
a length of 1410 bp.  Query C is the M13 Forward pBpals
sequence read from a DNA sequencing polyacrylamide gel.
Subject D is the P. putida pyrB gene and pyrC' gene with a
length of 1403 bp.  Query D is the M13 Reverse primer
sequence of pBpals read from a DNA sequencing
polyacrylamide gel.  Subject E is the P. putida pyrR gene
and pyrB gene with a length of 778 bp.
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Identities = 86/90 (95%), Gaps = 4/90 (4%)
Query A:25 ctgcagaatcacatcaaataaaaatgcatataccttgacttttaattcaaataaaccgtt
84         ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct A:340ctgcagaatcacatcaaataaaaatgcatataccttgacttttaattcaaataaaccgtt
399
Query A:85 t----tgacaaaatattgcatcaaatgctt 110
           |    |||||||||||||||||||||||||
Sbjct A:400tgcgctgacaaaatattgcatcaaatgctt 429
Identities = 70/73 (95%), Gaps = 3/73 (4%)
Query B:1  gacaattaa-catcggctcgtata-tgt-tggaattgtgagcggataacaatttcacaca
57         ||||||||| |||||||||||||| ||| |||||||||||||||||||||||||||||||
Sbjct B:145gacaattaatcatcggctcgtataatgtgtggaattgtgagcggataacaatttcacaca
86
Query B:58 ggaaacaggatcc 70
           |||||||||||||
Sbjct B:85 ggaaacaggatcc 73
Identities = 39/39 (100%)
Query B:27 tggaattgtgagcggataacaatttcacacaggaaacag 65
           |||||||||||||||||||||||||||||||||||||||
Sbjct B:257tggaattgtgagcggataacaatttcacacaggaaacag 219
Identities = 62/64 (96%), Gaps = 2/64 (3%)
Query B:74 gatctgatcaaaatcgaaaatacctttttgagtgaagatc-agtagatc-actggcattg
131        |||||||||||||||||||||||||||||||||||||||| |||||||| ||||||||||
Sbjt C:1117gatctgatcaaaatcgaaaatacctttttgagtgaagatcaagtagatcaactggcattg
1176
Query B:132 tatg 135
            ||||
Sbjct C:1177tatg 1180
Identities = 78/80 (97%), Gaps = 2/80 (2%)
Query C:30 tcactgggcgttctcctggtcgaattgaccgttgccgcgttctgcccgctcatggccatg
89         ||||||||||||||||||||||||||||| ||||| ||||||||||||||||||||||||
Sbjt D:1403tcactgggcgttctcctggtcgaattgac-gttgc-gcgttctgcccgctcatggccatg
1346
Query C:90  gacagcacggccatgcgcac 109
            ||||||||||||||||||||
Sbjct D:1345gacagcacggccatgcgcac 1326
75
Identities = 27/28 (96%), Gaps = 1/28 (3%)
Query D:1 ctaccgcgacgactt-agccagaacggc 27
          ||||||||||||||| ||||||||||||
Sbjct D:55ctaccgcgacgacttcagccagaacggc 82
Identities = 27/28 (96%), Gaps = 1/28 (3%)
Query D:1  ctaccgcgacgactt-agccagaacggc 27
           ||||||||||||||| ||||||||||||
Sbjct E:409ctaccgcgacgacttcagccagaacggc 436
Figure 13.  Plasmid maps of pNELLS and pCELLS.   Green arrows represent
sequencing primers.  Navy blue arrows represent primers associated with
insert DNA.
Figure 14.  Plasmid maps of pNPS and pCPS.  Green represents sequencing
primers.  Navy blue arrows represent primers associated with insert DNA.
Figure 15.  An agarose gel depicting the EcoRI and MluI restriction enzyme
digestion of pNELLS, pCELLS, pNPS, and pCPS.
  1    2    3     4    5    6    7    8    9    10   11   12    13   14
2.3 kbp
2.0 kbp
Lane 1.  Lambda DNA-HindIII Digest size marker.
Lane 2.  pGEM DNA size marker.
Lane 3.  Undigested pNPS.
Lane 4.  EcoRI digest of pNPS - 3.9 kbp linear vector, 260 bp insert DNA.
Lane 5.  MluI digest of pNPS - 4.16 kbp linear vector + insert DNA.
Lane 6.  Undigested pNELLS.
Lane 7.  EcoRI digest of pNELLS - 3.9 kbp linear vector, 440 bp insert DNA.
Lane 8.  MluI digest of pNELLS - 4.34 kbp linear vector + insert DNA.
Lane 9.  Undigested pCPS.
Lane 10.  EcoRI digest of pCPS - 3.9 kbp linear vector, 820 bp insert DNA.
Lane 11.  MluI digest of pCPS - 4.72 kbp linear vector + insert DNA.
Lane 12.  Undigested pCELLS.
Lane 13.  EcoRI digest of pCELLS - 3.9 kbp linear vector, 1055 bp insert DNA.
Lane 14.  MluI digest of pCELLS - 4.955 kbp linear vector + insert DNA.
6.5 kbp
4.3 kbp
Figure 16.  DNA sequence of the MluI site in pNELLS, pCELLS, pNPS, and pCPS.  An
autoradiograph of a chain-terminator sequencing gel, showing the sequence of
single stranded M13 recombinant DNA.  Purple represents the MluI cut site DNA


























Figure 17.  Insert-vector junction DNA sequence comparison
of pNELLS, pCELLS, pNPS, and pCPS with known E. coli, P.
putida, and pALTER-Ex1 cloning vector sequences.  The E.
coli, P. putida, and pALTER-Ex1 sequences were obtained
from GenBank and are available on the Internet at
http://www.ncbi.nlm.nih.gov.  Query A is the M13 Forward
primer sequence of pNELLS provided by AGCT, Inc.  Subject A
is the E. coli pyrBI operon encoding for ATCase with a
length of 1593 bp.  Subject B is the cloning vector,
pALTER-Ex1, complete vector sequence with a length of 5858
bp.  Query B is the M13 Forward primer sequence of pCELLS
provided by AGCT, Inc.  Subject C is the E.coli pyrBI
operon encoding ATCase with a length of 1410 bp.  Query C
is the M13 Reverse primer sequence of pCELLS provided by
AGCT, Inc.  Query D is the M13 Forward primer sequence of
pNPS provided by AGCT, Inc.  Subject D is P. putida pyrB
gene and pyrC' gene with a length of 1403 bp.  Query E is
the M13 Forward primer sequence of pCPS provided by AGCT,
Inc.  Query F is the M13 Reverse primer sequence of pCPS
provided by AGCT, Inc.  Red represents the single base
mutation, purple represents the MluI restriction enzyme
site, and blue represents inverted partial pyrI sequence.
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Identities = 436/453 (96%), Gaps = 7/453 (1%)
Query A:51 gaggcgggtacgcgtagaggcttcgaagaaacagctggcaatgactttgtgcttcaacag




























           |||||||||||||||||||||||||||||||||
Sbjct A:372gtatatgcatttttatttgatgtgattctgcag 340
Identities = 224/231 (96%), Gaps = 4/231 (1%)
Query A:576agcttgagtattctatagtgtcacctaaatagcttggcgtaatcatggtcatagctgttt













           || ||||||| |||||||||||||||||| |||||||||||||||||||||
Sbjct B:343tgcccgctttccagtcgggaaacctgtcgtgccagctgcattaatgaatcg 393
Identities = 662/672 (98%)
Query B:151gatctttgcggcccatctcgccagaaggcaggttcagaccaatggtgatgcgctgatccg













































           ||||||||||||
Sbjct C:460ccagacgcccct 449
Identities = 81/81 (100%)
Query B:70 gatctgatcaaaatcgaaaatacctttttgagtgaagatcaagtagatcaactggcattg




           |||||||||||||||||||||
Sbjt C:1177tatgcgccgcaagccacggtt 1197
Identities = 230/234 (98%)
Query C:52 gcctctacgcgtacccgcctctctttcgaaacatctatgcaccgcctgggggccagcgtg












           ||||||||||| ||||||||||||||||||||||||||||||||||||||||||
Sbjct C:334gcggcgcgccttgccaccgagttttccggcaatgtaccggtactgaatgccggt 387
Identities = 449/465 (96%), Gaps = 9/465 (1%)
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Query C:281ccggtactgaatgccggtgatggctccaaccaacatccgacgcaaaccttgctggactta




























           | ||||||| ||||||||||| |||||  ||||||||||||||||
Sbjct C:786g-aaagtgc-tgcatccgctg-ccgcg-cgttgatgagattgcga 826
Identities = 273/277 (98%), Gaps = 1/277 (0%)
Query D:52 gccctcgagcgccaggacctcgcctccgcttccgccctttaagagtcccccgcgatgacg

















           ||||||||||||||||||||||| |||||||||||||
Sbjct D:585aacgtgttcttcgagaactcgacccgtacccgcacca 621
Identities = 743/749 (99%), Gaps = 4/749 (0%)
Query E:28 gagaactcgacgcgtacccgcaccaccttcgaactggcggcccagcgcctgtcggccgac













































743        ||||||||||||||||||||||||||| ||||||||||||||||||||||||||||||||
Sbjt D:1257gaaatcgagtcggcggtggccgacggcaagcactcggtgatcctcaaccaggtcacctac
1316
Query E:744 ggcatcgccgtgcgcatggccgtgctgtc 772
            |||||||||||||||||||||||||||||
Sbjct D:1317ggcatcgccgtgcgcatggccgtgctgtc 1345
Identities = 578/586 (98%), Gaps = 7/586 (1%)
Query F:93 tcactgggcgttctcctggtcgaattgacgttgcgcgttctgcccgctcatggccatgga

































631        ||||||||||||| ||||||||||||||||| ||||||||||||||||||||||||||||
Sbjct D:925atggctaccgaga-ggttctcgaagctgccc-ttgtggcggcgaatggtgagcatgtcga
868
Query F:632 gcatg-cctgggtcgggtgcgcgt-gcggccgtcaccaccgttgat 675
            ||||| |||||||||||||||||| |||||||||||||||||||||
Sbjct D:867 gcatgccctgggtcgggtgcgcgtggcggccgtcaccaccgttgat 822
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Figure 18.  Insert-vector junction DNA sequence comparison
of pBJR28 with known E. coli pyrBI sequence.  The E. coli
sequence was obtained from GenBank and is available on the
Internet at http://www.ncbi.nlm.nih.gov.  Query A is the
M13 Forward primer sequence of pBJR28 read from a DNA
sequencing polyacrylamide gel.  Subject A is the E. coli
pyrBI operon start with leader peptide sequence with a
length of 1581 bp.  Query B is the M13 Reverse primer
sequence of pBJR28 read from a DNA sequencing
polyacrylamide gel.  Subject B is the E.coli pyrBI operon
encoding ATCase with a length of 1410 bp.
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Identities = 253/268 (94%), Gaps = 10/268 (3%)
Query A: 1 attcaaataaaccgtttgcgctgacaaaatattgcatcaaatgcttgcgccgcttctgac
















           |||| ||||||||||| |||||||||||
Sbjct A:624taatccgctatatcagaaacatatcatt 651
Identities = 174/178 (97%), Gaps = 1/178 (0%)
Query B:37 gatctttgcggcccatcacgccagaaggcaggttcagaccaatggtgatgcgctgatccg








213       ||||||| ||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct B:1000ttaccgtgccgcgtttaatagcttcaacctgcaatttattatcgtgtgtcatctctat
943
Identities = 34/36 (94%)
Query B: 1  gatcaactggcattgtatcccccgcaagccacggtt 36
            |||||||||||||||||| | |||||||||||||||
Sbjct B:1162gatcaactggcattgtatgcgccgcaagccacggtt 1197
Figure 19.  pBJR28 plasmid map.
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Figure 20.  Insert-vector junction DNA sequence comparison
of pAK10 with known P.putida pyrBC' sequence.  The P.
putida sequence was obtained from GenBank and is available
on the Internet at http://www.ncbi.nlm.nih.gov.  Query A is
the M13 Forward primer sequence of pAK10 read from a DNA
sequencing polyacrylamide gel.  Subject A is the P. putida
pyrB and pyrC' gene with a length of 1403 bp.  Query B is
the M13 Reverse primer sequence of pAK10 read from a DNA
sequencing polyacrylamide gel.  Subject B is the P. putida
pyrR and pyrB gene with a length of 778 bp.
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Identities = 246/261 (94%), Gaps = 14/261 (5%)
Query A: 6 tcactgggcgt-ctcctggtcgaattgacgttgcgcgt-ctgcccgctcatggccatgga












233      |||||||| |||||| ||||||| ||||||||||||||||||||||||||||||||||||
Sbjt A:1223gatggcgtcaggcttggcgcaggccaggcgcgcggtggtcaggccgaacaggcggtagaa
1164
Query A:234 ctcg--ctcgctgggcagcag 252
            ||||  |||||||||||||||
Sbjt A:1163 ctcgccctcgctgggcagcag 1143
Identities = 216/232 (93%), Gaps = 9/232 (3%)
Query B: 4 tctcgttctaccgcacgacgacttccagccagaaca-cct-cacccgcaacttcgcccgt












           || ||||||||||||||||||||||||||| |||||||||||||||||||||
Sbjct B:578gtcaccctggtctgcctgctggacctggatgccggcgaattgccgatccgtc 629
Identities = 21/21 (100%)
Query B:235ccggcgaattgccgatccgtc 255
           |||||||||||||||||||||
Sbjct B:609ccggcgaattgccgatccgtc 629
Figure 21.  pAK10 plasmid map.
Figure 22.  pBEP plasmid map.  Green arrows represent
sequencing primers.  Navy blue arrows represent primers


















1 Kpn I digestion
2 Fill-in reaction
3 Mlu I digestion
4  Ligation





Figure 23.  Schematic diagram demonstrating the genealogy of pBEP.
Figure 24. An agarose gel depicting the EcoRI and MluI restriction enzyme
digestion of pBEP.






Lane 1 and 3.  Lambda DNA- HindIII digest size marker.
Lane 2.        EcoRI digest of pBEP - 3.9 kbp linear vector, 1.6 kbp insert DNA.
Lane 4 and 5.  EcoRI and MluI digestion of pBEP - 3.9 kbp linear vector,
     820 bp E. coli pyrB polar domain insert DNA, 440 bp P. putida pyrB





Figure 25.  A nondenaturing polyacrylamide activity gel
of the ATCase from pBEP.
Lane 1. P. putida ATCase holoenzyme.
Lane 2. E. coli ATCase holoenzyme.
Lane 3. pBJR28 E. coli ATCase trimer within E. coli TB2.
Lane 4. pBEP hybrid ATCase trimer within E. coli TB2.
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